Oramed Pharmaceuticals Inc
Oramed Pharmaceuticals Inc (ORMP) Options Open Interest
ORMP options open interest is 710 contracts. The 2-week average daily volume is 16 contracts across the chain.
Read more
Monitoring ORMP open interest helps you see where real money is positioned on Oramed Pharmaceuticals Inc's options and which strikes are attracting the most commitment from traders. Oramed Pharmaceuticals Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor ORMP options open interest in real time and find the strikes that matter.
Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising ORMP options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Oramed Pharmaceuticals Inc to settle.
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes. It is also developing ORMD-0901, an oral glucagon-like peptide-1 capsule that has completed phase I clinical trials for the treatment of type 2 diabetes; and a weight loss treatment in the form of an oral leptin capsule.
The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York.
Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where ORMP open interest is concentrated. Our scanner maps Oramed Pharmaceuticals Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Oramed Pharmaceuticals Inc's options open interest as the signal it is, not as an afterthought.
| 5.00 | — | 0.65 | 0.65 | 146% | +0.5287 | 3 |
| 2.50 | 0.20 | 4.40 | 2.30 | 165% | +0.9507 | 0 |
| 7.50 | — | 2.15 | 2.15 | 561% | +0.6803 | 0 |
| 2.50 | — | 2.15 | 2.15 | 1,000% | -0.0548 | 1 |
| 5.00 | — | 2.60 | 2.60 | 505% | -0.2571 | 0 |
| 7.50 | 0.70 | 4.90 | 2.80 | 116% | -0.9006 | 0 |
As of September 18, 2026
Follow the money
Track ORMP open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.
Start your 14-day free trial→